Page 71 - Preliminary Program Science Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preliminary program science technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preliminary Program Science Technology Today - Breaking & Trending Today

ADVA achieves record profitability with preliminary Q4 2020 financial results

Quarterly revenues EUR 140.6 million, annual EUR 565.0 million at the lower end of guidance Quarterly pro forma operating income EUR 14.4 million (10.2% of revenues), annual EUR 33.8 million ....

Uli Dopfer , Brian Protiva , Stephan Rettenberger , Gareth Spence , கரேத் ஸ்பென்ஸ் ,

Klaipedos Nafta: AB Klaipedos nafta preliminary revenue for the December 2020


Klaipedos Nafta: AB Klaipedos nafta preliminary revenue for the December 2020
Oil terminals activity, that includes Klaipeda oil terminal and Subacius oil terminal,
Regulated Klaipeda LNG Terminal activity and
Commercial LNG activity, that includes small-scale LNG reloading station in Klaipeda and international Business development projects.
The preliminary sales revenue of the Company s oil terminals for the December 2020 comprise EUR 2.5 million and is lower by EUR 1.0 million or by 28.6 % compared to December of 2019. The preliminary sales revenue of the Company s oil terminals for the twelve months of 2020 comprise EUR 31.3 million and is lower by 5.2 % compared to the same period of 2019.
The preliminary sales revenue of the Company s Klaipeda LNG terminal for December 2020 comprise EUR 3.6 million (during the same month of 2019 - EUR 5.9 million). Klaipeda LNG terminal revenue from regulated activities consists of the regasification tariff fixed part (for ....

Klaipedos Apskritis , Lithuania General , Jonas Lenk , Company Klaipeda , National Energy Regulatory Council , Company Commercial , Company For The , Chief Financial Officer , லிதுவேனியா ஜநரல் , ஜோனாஸ் லேங்க் , தேசிய ஆற்றல் ஒழுங்குமுறை சபை , நிறுவனம் வணிகரீதியானது , நிறுவனம் க்கு தி , தலைமை நிதி அதிகாரி ,

Neurocrine Biosciences Preliminary Full-Year INGREZZA Net Product Sales Up 32%


Neurocrine Biosciences Preliminary Full-Year INGREZZA Net Product Sales Up 32%
WASHINGTON (dpa-AFX) - Neurocrine Biosciences, Inc. (NBIX) said, based on preliminary unaudited financial information, the company expects INGREZZA net product sales for the three months and full-year ended December 31, 2020 to be approximately $240 million and $993 million respectively. INGREZZA inventory adjusted net product sales for the fourth quarter were approximately $258 million. Full-year 2020 total INGREZZA prescriptions grew 32% to approximately 175,700.
The company said it plans to provide clinical data for key programs and expects to begin seven additional mid-to-late stage clinical studies in 2021 for neurological, endocrine and psychiatric disorders.
Copyright RTT News/dpa-AFX
© 2021 AFX News ....

United States , Neurocrine Biosciences Inc , ஒன்றுபட்டது மாநிலங்களில் ,